Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) saw a large growth in short interest during the month of February. As of February 29th, there was short interest totalling 765,100 shares, a growth of 1,566.9% from the February 14th total of 45,900 shares. Based on an average daily volume of 680,600 shares, the days-to-cover ratio […]
Several stocks are currently undergoing noteworthy developments, making them worthy of closer monitoring. This feature will delve into five stocks that merit inclusion in watch lists, offering.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specializing in oncology, today announced the early conclusion based on.
Wednesday morning, Kazia Therapeutics Limited KZIA announced the early conclusion based on safety and clinical response findings observed to date of an…